+1,173.1%
MRVL vs CVS
+63.8%
+1,109.4%
-61.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.7% | -0.5% | -4.2% | -4.6% |
| 7D | +11.0% | +6.6% | +4.5% | +9.7% |
| 30D | -36.1% | -0.4% | -35.6% | -36.1% |
| 3M | -29.4% | -5.3% | -24.2% | -29.0% |
| 6M | -11.9% | -7.7% | -4.2% | -11.2% |
| YTD | +84.8% | +16.0% | +68.7% | +75.5% |
| 1Y | +79.4% | +16.2% | +63.2% | +70.1% |
| 3Y | +195.7% | +47.6% | +148.2% | +155.3% |
| 5Y | +117.2% | +12.3% | +104.9% | +107.3% |
| All | +1,173.1% | +63.8% | +1,109.4% | +918.8% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling